Cafepharma Today

June 13 2025 - Merck's Keytruda wins breakthrough head and neck cancer nod around surgery, but with a limitation
Merck's Keytruda wins breakthrough head and neck cancer nod around surgery, but with a limitation
Moderna falls on doubts over new CDC panel's backing of RSV vaccine
Urogen’s bladder cancer drug wins FDA approval over adcomm’s objections
A day in the life of GSK’s U.S. president
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Can J&J Get Its Diabetes Drug Past the Safety-First FDA?
Motley Fool
Monday, January 14, 2013 - 12:00pm
tags:
JNJ, diabetes, FDA, canagliflozin
[video]Dendreon: 3 Areas You Must Watch
Motley Fool
Monday, January 14, 2013 - 11:59am
tags:
Dendreon, Provenge
AbbVie Deserves A Chance
Seeking Alpha
Monday, January 14, 2013 - 11:58am
tags:
AbbVie, Abbott Laboratories
The Soft Underbelly of ZIOPHARM Oncology
Motley Fool
Monday, January 14, 2013 - 11:57am
tags:
Ziopharm
Novartis Earnings: How Will They Grow?
Motley Fool
Monday, January 14, 2013 - 10:35am
tags:
earnings, Novartis
4 Can't-Miss Health-Care Events to Watch For This Week
Motley Fool
Monday, January 14, 2013 - 10:26am
tags:
Santarus, Uceris, Zecuity, NuPathe, Forest Labs
William Blair Analysts Are Gaining Comfort Ahead Of Dynavax's Heplisav PDUFA
Seeking Alpha
Monday, January 14, 2013 - 10:18am
tags:
Dynavax, Heplisav, hepatitis B
1 Great Dividend You Can Buy Right Now
Motley Fool
Saturday, January 12, 2013 - 11:17am
tags:
JNJ
Is Teva Just Looking Out for Itself
Motley Fool
Saturday, January 12, 2013 - 11:14am
tags:
Teva, Copaxone, multiple sclerosis, MS, generics, Biogen, BG-12
Man Taking Generic Drug Can Sue Branded Maker
NY Times
Saturday, January 12, 2013 - 11:13am
tags:
generics, lawsuits
AbbVie recalling thyroid drug
Yahoo/AP
Saturday, January 12, 2013 - 11:11am
tags:
AbbVie, Synthroid, thyroid, recalls
Merck Pulls the Plug
Motley Fool
Saturday, January 12, 2013 - 11:06am
tags:
Merck, Tredaptive, cholesterol
Can J&J Get Its Diabetes Drug Past the Safety-First FDA?
Motley Fool
Saturday, January 12, 2013 - 11:05am
tags:
JNJ, canagliflozin, diabetes, type 2 diabetes
J&J's Prostate Cancer Drug Zytiga Approved for Earlier Use in EU
Motley Fool
Saturday, January 12, 2013 - 11:04am
tags:
JNJ, Zytiga, prostate cancer
4 Healthcare Stock Stories for Investor Wellbeing
Wall Street Cheat Street
Saturday, January 12, 2013 - 10:59am
tags:
JNJ, Telik, AbbVie, Pfizer
Isis Wins at Wooing Wall Street
Motley Fool
Saturday, January 12, 2013 - 10:50am
tags:
Isis Pharmaceuticals
3 Humongous Health-Care Stocks This Week
Motley Fool
Saturday, January 12, 2013 - 10:47am
tags:
Isis Pharmaceuticals, Celgene, Dynavax Technologies
3 Biotech Growth Stocks Near Highs
Seeking Alpha
Saturday, January 12, 2013 - 10:45am
tags:
Celgene, Valiant, Regeneron
Trader thinks Jazz may hit sour note
Yahoo/Option Monster
Saturday, January 12, 2013 - 10:45am
tags:
Jazz Pharmaceuticals
Which Companies Are In Michael King's Oncology Wheelhouse?
Seeking Alpha
Saturday, January 12, 2013 - 10:44am
tags:
Alnylam, Regulus, Isis Pharmaceuticals, SynaGeva BioPharma, Sarepta Therapeutics, Onyx, Celgene, Millennium, Takeda, Ariad Pharmaceuticals, Pharmacyclics, Astex

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.